133 related articles for article (PubMed ID: 7873996)
41. Epstein-Barr virus recombinants from overlapping cosmid fragments.
Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
[TBL] [Abstract][Full Text] [Related]
42. Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin's lymphomas.
Lin JC; Lin SC; Luppi M; Torelli G; Mar EC
J Med Virol; 1995 Feb; 45(2):183-91. PubMed ID: 7775937
[TBL] [Abstract][Full Text] [Related]
43. Frequent presence of subtype A virus in Epstein-Barr virus-associated malignancies.
Peh SC; Kim LH; Poppema S
Pathology; 2002 Oct; 34(5):446-50. PubMed ID: 12408344
[TBL] [Abstract][Full Text] [Related]
44. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
45. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
Sample C; Parker B
Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
[TBL] [Abstract][Full Text] [Related]
46. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise.
Boyle MJ; Vasak E; Tschuchnigg M; Turner JJ; Sculley T; Penny R; Cooper DA; Tindall B; Sewell WA
Blood; 1993 Jan; 81(2):468-74. PubMed ID: 8380726
[TBL] [Abstract][Full Text] [Related]
47. [Development of a polymerase chain reaction (PCR) system for detection of Epstein-Barr virus 1,2--application to various tonsillar disorders].
Kunimoto M
Nihon Jibiinkoka Gakkai Kaiho; 1994 May; 97(5):868-79. PubMed ID: 8207602
[TBL] [Abstract][Full Text] [Related]
48. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
[TBL] [Abstract][Full Text] [Related]
49. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
50. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
52. [Detection of Epstein-Barr virus subtypes in Hodgkin's disease].
Zhou X; Li P; Ji X
Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):255-7. PubMed ID: 11244991
[TBL] [Abstract][Full Text] [Related]
53. A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease.
Gan YJ; Razzouk BI; Su T; Sixbey JW
Am J Pathol; 2002 Mar; 160(3):781-6. PubMed ID: 11891176
[TBL] [Abstract][Full Text] [Related]
54. [The EBNA2 coding region in the viral genome of Epstein-Barr virus (EBV)-positive cases of Hodgkin's disease].
Borisch B; Telenti A; Hennig I; Marchesi F; Audouin J; Diebold J; Pallesen G
Verh Dtsch Ges Pathol; 1992; 76():181-4. PubMed ID: 1336913
[TBL] [Abstract][Full Text] [Related]
55. Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene.
Tsai CN; Liu ST; Chang YS
DNA Cell Biol; 1995 Sep; 14(9):767-76. PubMed ID: 7669254
[TBL] [Abstract][Full Text] [Related]
56. EBNA-1 gene sequences in Brazilian and American patients with Hodgkin's disease.
Chang KL; Chen YY; Chen WG; Hayashi K; Bacchi C; Bacchi M; Weiss LM
Blood; 1999 Jul; 94(1):244-50. PubMed ID: 10381519
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
[TBL] [Abstract][Full Text] [Related]
58. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
59. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]